Nanovibronix Revenue and Competitors
Estimated Revenue & Valuation
- Nanovibronix's estimated annual revenue is currently $1M per year.
- Nanovibronix's estimated revenue per employee is $84,000
Employee Data
- Nanovibronix has 12 Employees.
- Nanovibronix grew their employee count by 0% last year.
Nanovibronix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | Sales Manager | Reveal Email/Phone |
Nanovibronix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Nanovibronix?
N/A
Total Funding
12
Number of Employees
$1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nanovibronix News
2022-04-19 - NanoVibronix Adds Additional Product to Federal Supply Schedule
NanoVibronix, Inc. (NASDAQ: NAOV) is a medical device company headquartered in Elmsford, New York, with research and development in Nesher,...
2022-03-30 - NanoVibronix: Buy, Sell, or Hold
NanoVibronix, Inc. (NAOV) in Elmsford, N.Y., is a medical device company that specializes in developing medical devices based on its unique low-...
2022-03-22 - NanoVibronix Announces PainGuard and UroGuard Approved by ...
--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.2M | 12 | -77% | $263.3M |
#2 | $1.1M | 12 | 0% | N/A |
#3 | $0.9M | 12 | -29% | N/A |
#4 | $1M | 12 | 9% | N/A |
#5 | $1M | 12 | N/A | N/A |